These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14524362)

  • 1. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Mittendorf R; Pryde PG; Lee KS
    Am J Obstet Gynecol; 2003 Aug; 189(2):613. PubMed ID: 14524362
    [No Abstract]   [Full Text] [Related]  

  • 2. Antenatal magnesium sulfate for neuroprotection before preterm birth?
    Stanley FJ; Crowther C
    N Engl J Med; 2008 Aug; 359(9):962-4. PubMed ID: 18753653
    [No Abstract]   [Full Text] [Related]  

  • 3. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Mittendorf R; Dambrosia J; Pryde PG; Lee KS; Gianopoulos JG; Besinger RE; Tomich PG
    Am J Obstet Gynecol; 2002 Jun; 186(6):1111-8. PubMed ID: 12066082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Usta IM; Nassar AH
    Am J Obstet Gynecol; 2003 Aug; 189(2):614-5; author reply 615-6. PubMed ID: 14524364
    [No Abstract]   [Full Text] [Related]  

  • 5. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection.
    Obstet Gynecol; 2010 Mar; 115(3):669-671. PubMed ID: 20177305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor.
    Mittendorf R; Roizen NJ; Pryde PG
    J Perinatol; 2004 Jul; 24(7):465-6. PubMed ID: 15224123
    [No Abstract]   [Full Text] [Related]  

  • 7. In defense of magnesium sulfate.
    Elliott JP; Lewis DF; Morrison JC; Garite TJ
    Obstet Gynecol; 2009 Jun; 113(6):1341-1348. PubMed ID: 19461432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does antenatal magnesium sulfate prevent cerebral palsy in preterm infants? The final trial?
    Huusom LD; Brok J; Hegaard HK; Pryds O; Secher NJ
    Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1346-7. PubMed ID: 23016563
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnesium sulfate for the prevention of cerebral palsy.
    Mittendorf R; Pryde PG
    N Engl J Med; 2009 Jan; 360(2):189-90; author reply 190. PubMed ID: 19129535
    [No Abstract]   [Full Text] [Related]  

  • 10. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants.
    Costantine MM; Drever N
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):351-66, xi. PubMed ID: 21575805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor.
    Mittendorf R; Dammann O; Lee KS
    J Perinatol; 2006 Jan; 26(1):57-63. PubMed ID: 16319938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal magnesium sulphate.
    Peebles DM; Marlow N; Brocklehurst P
    BMJ; 2010 Nov; 341():c6004. PubMed ID: 21097982
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.
    Rouse DJ; Hirtz DG; Thom E; Varner MW; Spong CY; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Alexander JM; Harper M; Thorp JM; Ramin SM; Malone FD; Carpenter M; Miodovnik M; Moawad A; O'Sullivan MJ; Peaceman AM; Hankins GD; Langer O; Caritis SN; Roberts JM;
    N Engl J Med; 2008 Aug; 359(9):895-905. PubMed ID: 18753646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-benefit effects of tocolytic therapy.
    Pryde PG; Janeczek S; Mittendorf R
    Expert Opin Drug Saf; 2004 Nov; 3(6):639-54. PubMed ID: 15500422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium sulfate for preterm neuroprotection.
    Mittendorf R; Lee KS; Roizen NJ; Pryde PG
    JAMA; 2004 Feb; 291(8):940-1; author reply 941. PubMed ID: 14982906
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Rouse DJ; Hirtz DG; Thom E
    Am J Obstet Gynecol; 2003 Jan; 188(1):295. PubMed ID: 12548234
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    McElrath TF
    Am J Obstet Gynecol; 2003 Jan; 188(1):294; author reply 294-5. PubMed ID: 12548232
    [No Abstract]   [Full Text] [Related]  

  • 18. The choice of tocolytic drugs for preterm labor- comparison of COX-2 inhibitor and magnesium sulfate.
    Wang PH; Cheng MH; Lee WL
    J Obstet Gynaecol Res; 2008 Jun; 34(3):439-40. PubMed ID: 18588623
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of magnesium sulfate in the prevention of cerebral palsy.
    Scheans P
    Neonatal Netw; 2012; 31(2):121-4. PubMed ID: 22397798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium sulfate during anticipated preterm birth for infant neuroprotection.
    Merrill L
    Nurs Womens Health; 2013; 17(1):42-51. PubMed ID: 23399012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.